Gallant Therapeutics raises more than $15 million to advance "off-the-shelf" stem cell therapies for pets
Gallant Therapeutics intends to deliver off-the-shelf stem cell therapies that target the root cause of major diseases in pets.
top of page
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Veterinary and Animal Health
bottom of page